A comprehensive map of genes necessary for cancer survival is one step closer, following validation of the two largest CRISPR-Cas9 genetic screens in 725 cancer models, across 25 different cancer types. Scientists compared the consistency of the two datasets, independently verifying the methodology and findings. The study will help speed the discovery and development of new cancer drugs.